Marit Ahrens

807 citations
22 papers · 378 indexed · h-index 9
Topics
Renal cell carcinoma treatment (7 papers)Radiopharmaceutical Chemistry and Applications (5 papers)Sarcoma Diagnosis and Treatment (5 papers)

In The Last Decade

Marit Ahrens

21 papers receiving 374 citations

Peers

Marit Ahrens
Comparison fields: 5 of 47
  • Oncology 226
  • Pulmonary and Respiratory Medicine 171
  • Cancer Research 108
  • Surgery 108
  • Molecular Biology 107
Replace Dušica Gavrilović with:
Dušica Gavrilović Serbia
Daniela Paccagnella Italy
Nüvi̇t Duraker Türkiye
Cihan Gündoğan Türkiye
Wenqi Xi China
Yoshimasa Oku Japan
Emma J. Groen Netherlands
Bodil Elisabeth Engelmann Denmark
Marit Ahrens relative to Dušica Gavrilović Serbia Dušica Gavrilović's profile →
Citations per field
00.5×4.2×
Dušica Gavrilović · 1×
Citations per year

Countries citing papers authored by Marit Ahrens

Since Specialization
Citations

This map shows the geographic impact of Marit Ahrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Ahrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Ahrens more than expected).

Fields of papers citing papers by Marit Ahrens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit Ahrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Ahrens. The network helps show where Marit Ahrens may publish in the future.

Co-authorship network of co-authors of Marit Ahrens

This figure shows the co-authorship network connecting the top 25 collaborators of Marit Ahrens. A scholar is included among the top collaborators of Marit Ahrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marit Ahrens. Marit Ahrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 14
4 5
5 0
6 91
7 27
8 91
9 11
10 7
11 6
12 1
13 9
14 3
15 1
16 1
17 39
18 15
19 2
20 4

About Marit Ahrens

Marit Ahrens is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Cancer Research, having authored 22 papers that have together received 378 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (226 citations), Cancer Research (108 citations) and Pulmonary and Respiratory Medicine (171 citations). Marit Ahrens has collaborated with scholars based in Germany, United Kingdom and Spain. Frequent co-authors include Sebastian Bauer, Martin Schüler, Rainer Hamacher, Lothar Bergmann, Ken Herrmann, Pedro Fragoso Costa, Manuel Weber, Justin Ferdinandus, Wolfgang P. Fendler and Christoph Rischpler. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026